Selective contrast-enhanced computed tomography is appropriate in diffuse large B-cell lymphoma therapy response assessment.

Kriegsmann, Katharina; Wack, Maurizio; Kriegsmann, Mark; Cremer, Martin; Bruckner, Thomas; Ho, Anthony D; Wuchter, Patrick; Witzens-Harig, Mathias

Kriegsmann, Katharina; Wack, Maurizio; Kriegsmann, Mark; Cremer, Martin; Bruckner, Thomas; Ho, Anthony D; Wuchter, Patrick; Witzens-Harig, Mathias.

Afiliação

Kriegsmann K; Department of Hematology, Oncology and Rheumatology, Heidelberg University, Heidelberg, Germany.
Wack M; Department of Hematology, Oncology and Rheumatology, Heidelberg University, Heidelberg, Germany.
Kriegsmann M; Institute of Pathology, Heidelberg University, Heidelberg, Germany.
Cremer M; Department of Hematology, Oncology and Rheumatology, Heidelberg University, Heidelberg, Germany.
Bruckner T; Institute of Medical Biometry and Informatics, Heidelberg University, Heidelberg, Germany.
Ho AD; Department of Hematology, Oncology and Rheumatology, Heidelberg University, Heidelberg, Germany.
Wuchter P; Medical Faculty Mannheim, Institute of Transfusion Medicine and Immunology, German Red Cross Blood Service Baden-Württemberg - Hessen, Heidelberg University, Mannheim, Germany.
Witzens-Harig M; Department of Hematology, Oncology and Rheumatology, Heidelberg University, Heidelberg, Germany.

Eur J Haematol ; 2018 Jul 24.

Article em En | MEDLINE | ID: mdl-30047174

Palavras-chave

DLBCL; computed tomography; end staging; interim staging

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Eur J Haematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google